CommercialMedicare AdvantageMedicaidJune 30, 2023

July 2023 Provider Newsletter

Featured Articles

Digital SolutionsCommercialJune 30, 2023

Requests for Additional Information are now digital

Products & ProgramsCommercialMedicare AdvantageMedicaidJune 30, 2023

Advancing health equity: Leveraging data to promote meaningful patient-provider relationships


Administrative

AdministrativeMedicare AdvantageJune 30, 2023

Unspecified diagnosis code of site and laterality

AdministrativeCommercialJune 22, 2023

Update for COVID-19 vaccine administration codes

AdministrativeCommercialJune 30, 2023

Maintain your online provider directory information

Education & Training

Education & TrainingCommercialJune 22, 2023

Newborn authorizations and baby names

Education & TrainingMedicare AdvantageJune 30, 2023

Required training - Model of Care

Education & TrainingCommercialMedicare AdvantageJune 30, 2023

The BlueCard Provider Manual can answer your questions about the program

Policy Updates

Policy UpdatesMedicaidJune 12, 2023

Clinical Criteria Updates for February 2023

Policy UpdatesMedicaidJune 9, 2023

Clinical Criteria updates for December 2022

Medical Policy & Clinical GuidelinesMedicaidJune 13, 2023

Access to Care Standards

Medical Policy & Clinical GuidelinesMedicare AdvantageJune 26, 2023

Medical Policies and Clinical Utilization Management Guidelines update for February 2023

Prior AuthorizationMedicaidJune 26, 2023

Medical Prior Authorization update Fylnetra, Rolvedon, and Stimufend

Prior AuthorizationMedicaidMay 31, 2023

Cimerli Medical Prior Authorization update

Prior AuthorizationMedicare AdvantageJune 5, 2023

Carelon Medical Benefits Management, Inc. genetic testing CPT code list update

Prior AuthorizationMedicaidMay 31, 2023

Prior authorization requirement changes effective September 1, 2023

Prior AuthorizationMedicaidJune 1, 2023

Spevigo and Xenpozyme Medical Prior Authorization update

Products & Programs

PharmacyMedicare AdvantageJune 26, 2023

Medicare Part B Precert expansion may multiple drug alignment

CABC-CDCRCM-027098-23